Co-Diagnostics, Inc. Operating Income
Co-Diagnostics, Inc. (CODX) reported Operating Income of -$6.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- Co-Diagnostics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$6.20M.
- Co-Diagnostics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$9.21M.
- Co-Diagnostics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$26.54M.
- Co-Diagnostics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$7.01M.
- Co-Diagnostics, Inc. operating income (loss) for fiscal 2025 was -$50.17M.
- Co-Diagnostics, Inc. operating income (loss) for fiscal 2024 was -$40.08M.
- Co-Diagnostics, Inc. operating income (loss) for fiscal 2023 was -$42.71M.
- Co-Diagnostics, Inc. operating income (loss) for fiscal 2022 was -$26.98M, a 158.57% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.20M 10-Q · filed 2026-08-13 | -$15.41M 10-Q · filed 2026-08-13 | -$41.95M derived: sum of 3 quarters · filed 2026-08-13 | -$48.96M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$9.21M 10-Q · filed 2026-05-14 | -$35.75M derived: sum of 2 quarters · filed 2026-05-14 | -$42.76M derived: sum of 3 quarters · filed 2026-05-14 | -$50.82M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$26.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$33.56M derived: sum of 2 quarters · filed 2026-03-31 | -$41.61M derived: sum of 3 quarters · filed 2026-08-13 | -$50.17M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$7.01M 10-Q · filed 2025-11-13 | -$15.07M derived: sum of 2 quarters · filed 2026-08-13 | -$23.62M 10-Q · filed 2025-11-13 | -$35.53M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$8.06M 10-Q · filed 2026-08-13 | -$16.61M 10-Q · filed 2026-08-13 | -$28.52M derived: sum of 3 quarters · filed 2026-08-13 | -$38.75M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$8.55M 10-Q · filed 2026-05-14 | -$20.46M derived: sum of 2 quarters · filed 2026-05-14 | -$30.69M derived: sum of 3 quarters · filed 2026-05-14 | -$38.37M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$11.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$22.14M derived: sum of 2 quarters · filed 2026-03-31 | -$29.82M derived: sum of 3 quarters · filed 2026-03-31 | -$40.08M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$10.23M 10-Q · filed 2025-11-13 | -$17.91M derived: sum of 2 quarters · filed 2025-11-13 | -$28.17M 10-Q · filed 2025-11-13 | -$40.00M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$7.68M 10-Q · filed 2025-08-14 | -$17.94M 10-Q · filed 2025-08-14 | -$29.76M derived: sum of 3 quarters · filed 2025-08-14 | -$38.70M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$10.26M 10-Q · filed 2025-05-08 | -$22.08M derived: sum of 2 quarters · filed 2025-05-08 | -$31.02M derived: sum of 3 quarters · filed 2025-05-08 | -$43.01M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$11.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$20.76M derived: sum of 2 quarters · filed 2025-03-27 | -$32.76M derived: sum of 3 quarters · filed 2025-03-27 | -$42.71M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$8.94M 10-Q · filed 2024-11-07 | -$20.93M derived: sum of 2 quarters · filed 2024-11-07 | -$30.88M 10-Q · filed 2024-11-07 | -$57.00M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$11.99M 10-Q · filed 2024-08-08 | -$21.95M 10-Q · filed 2024-08-08 | -$48.07M derived: sum of 3 quarters · filed 2024-08-08 | -$54.60M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$9.95M 10-Q · filed 2024-05-09 | -$36.07M derived: sum of 2 quarters · filed 2024-05-09 | -$42.61M derived: sum of 3 quarters · filed 2024-05-09 | -$46.75M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$26.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$32.66M derived: sum of 2 quarters · filed 2024-03-14 | -$36.80M derived: sum of 3 quarters · filed 2024-03-14 | -$26.98M 10-K · filed 2024-03-14 | -$26.98M 10-K · filed 2023-03-16 | ||
| 2022-09-30 | -$6.54M 10-Q · filed 2023-11-09 | -$10.68M derived: sum of 2 quarters · filed 2023-11-09 | -$858.49K 10-Q · filed 2023-11-09 | $9.45M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$4.15M 10-Q · filed 2023-08-10 | $5.68M 10-Q · filed 2023-08-10 | $15.99M derived: sum of 3 quarters · filed 2023-08-10 | $29.62M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $9.82M 10-Q · filed 2023-05-11 | $20.13M derived: sum of 2 quarters · filed 2023-05-11 | $33.76M derived: sum of 3 quarters · filed 2023-05-11 | $45.55M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $23.94M derived: sum of 2 quarters · filed 2023-03-16 | $35.73M derived: sum of 3 quarters · filed 2023-03-16 | $46.06M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $13.63M 10-Q · filed 2022-11-10 | $25.42M derived: sum of 2 quarters · filed 2022-11-10 | $35.76M 10-Q · filed 2022-11-10 | $51.79M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $11.79M 10-Q · filed 2022-08-11 | $22.13M 10-Q · filed 2022-08-11 | $38.16M derived: sum of 3 quarters · filed 2022-08-11 | $50.19M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $10.33M 10-Q · filed 2022-05-12 | $26.36M derived: sum of 2 quarters · filed 2022-05-12 | $38.40M derived: sum of 3 quarters · filed 2022-05-12 | $53.11M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $16.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $28.07M derived: sum of 2 quarters · filed 2022-03-24 | $42.78M derived: sum of 3 quarters · filed 2022-03-24 | $41.69M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $12.04M 10-Q · filed 2021-11-12 | $26.75M derived: sum of 2 quarters · filed 2021-11-12 | $25.66M 10-Q · filed 2021-11-12 | $24.04M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $14.71M 10-Q · filed 2021-08-12 | $12.34M 10-Q · filed 2020-08-13 | $13.63M 10-Q · filed 2021-08-12 | $11.26M 10-Q · filed 2020-08-13 | $12.00M derived: sum of 3 quarters · filed 2021-08-12 | $10.35M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$1.08M 10-Q · filed 2021-05-13 | -$2.71M derived: sum of 2 quarters · filed 2021-05-13 | -$4.36M derived: sum of 3 quarters · filed 2021-05-13 | -$5.72M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$3.27M derived: sum of 2 quarters · filed 2021-03-25 | -$4.64M derived: sum of 3 quarters · filed 2021-03-25 | -$5.89M 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$1.65M 10-Q · filed 2020-11-16 | -$3.02M derived: sum of 2 quarters · filed 2020-11-16 | -$4.27M 10-Q · filed 2020-11-16 | -$6.09M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | -$1.37M 10-Q/A · filed 2020-11-03 | -$2.62M 10-Q/A · filed 2020-11-03 | -$4.44M derived: sum of 3 quarters · filed 2020-11-03 | -$6.11M derived: sum of 4 quarters · filed 2020-11-03 | |||
| 2019-03-31 | -$1.25M 10-Q · filed 2020-05-14 | -$3.08M derived: sum of 2 quarters · filed 2020-05-14 | -$4.74M derived: sum of 3 quarters · filed 2020-05-14 | -$6.09M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.49M derived: sum of 2 quarters · filed 2020-03-30 | -$4.84M derived: sum of 3 quarters · filed 2020-03-30 | -$6.12M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$1.66M 10-Q · filed 2019-11-12 | -$3.02M derived: sum of 2 quarters · filed 2019-11-12 | -$4.29M 10-Q · filed 2019-11-12 | -$5.79M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$1.35M 10-Q · filed 2019-08-14 | -$2.63M 10-Q · filed 2019-08-14 | -$4.12M derived: sum of 3 quarters · filed 2019-08-14 | -$5.93M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$1.28M 10-Q · filed 2019-05-14 | -$2.77M derived: sum of 2 quarters · filed 2019-05-14 | -$4.58M derived: sum of 3 quarters · filed 2019-05-14 | -$5.28M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.30M derived: sum of 2 quarters · filed 2019-04-01 | -$4.00M derived: sum of 3 quarters · filed 2019-04-01 | -$4.56M 10-K · filed 2019-04-01 | |||
| 2017-09-30 | -$1.81M 10-Q · filed 2018-11-14 | -$2.51M derived: sum of 2 quarters · filed 2018-11-14 | -$3.07M 10-Q · filed 2018-11-14 | -$3.51M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$700.95K 10-Q · filed 2018-08-10 | -$1.27M 10-Q · filed 2018-08-10 | -$1.71M derived: sum of 3 quarters · filed 2018-08-10 | -$2.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | -$564.37K 10-Q · filed 2018-05-14 | -$1.01M derived: sum of 2 quarters · filed 2018-05-14 | -$1.40M derived: sum of 3 quarters · filed 2018-05-14 | -$1.79M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$444.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$836.93K derived: sum of 2 quarters · filed 2018-03-28 | -$1.23M derived: sum of 3 quarters · filed 2018-03-28 | -$1.69M 10-K · filed 2018-03-28 | |||
| 2016-09-30 | -$392.35K 10-Q · filed 2017-11-14 | -$782.64K derived: sum of 2 quarters · filed 2017-11-14 | -$1.24M 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | -$390.29K 10-Q · filed 2017-08-25 | -$851.04K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |